Concepedia

Joanna Regis

JR

Statistics

Publications

9

Citations

717

H-Index

9

Active since

1995

Affiliations

National Cancer Institute(Current)

National Institutes of Health

Joanna Regis is an author at National Cancer Institute specializing in medicine, pharmacology, and oncology.

Publications per year

1995–2001

9

Publications

9

A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2)

Robert W. Robey, Yasumasa Honjo, Anne van de Laar et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 2001 · 245 citations · Full text

Medicine, Molecular Biology, Pharmacology +11

Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy.

Wyndham H. Wilson, Susan E. Bates, Antonio Tito Fojo et al. · Journal of Clinical Oncology · 1995 · 124 citations

Medicine, Pharmacology, Pharmacotherapy +13

Detection of in vivo P-glycoprotein inhibition by PSC 833 using Tc-99m sestamibi.

C C Chen, Beverly Meadows, Joanna Regis et al. · PubMed · 1997 · 103 citations

Medicine, Oncology, Pharmacology +16

Normal p53 status and function despite the development of drug resistance in human breast cancer cells.

Katja Wosikowski, Joanna Regis, Robert W. Robey et al. · PubMed · 1995 · 72 citations

Medicine, Oncology, Pharmacology +17

Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomas.

Wyndham H. Wilson, Bruce A. Chabner, G Bryant et al. · Journal of Clinical Oncology · 1995 · 52 citations

Medicine, Oncology, Pharmacology +14

1–5 of 9